189 related articles for article (PubMed ID: 3417365)
21. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.
Colapinto EV; Humphrey PA; Zalutsky MR; Groothuis DR; Friedman HS; de Tribolet N; Carrel S; Bigner DD
Cancer Res; 1988 Oct; 48(20):5701-7. PubMed ID: 3167830
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
[TBL] [Abstract][Full Text] [Related]
23. Retargeting of human lymphocytes against human ovarian carcinoma cells by bispecific antibodies: from laboratory to clinic.
Mezzanzanica D; Canevari S; Colnaghi MI
Int J Clin Lab Res; 1991; 21(2):159-64. PubMed ID: 1815760
[TBL] [Abstract][Full Text] [Related]
24. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
[TBL] [Abstract][Full Text] [Related]
26. Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts.
Ward BG; Wallace K
Cancer Res; 1987 Sep; 47(17):4714-8. PubMed ID: 3621167
[TBL] [Abstract][Full Text] [Related]
27. Improved radioimmunoimaging of human tumor xenografts by a mixture of monoclonal antibody F(ab')2 fragments.
Munz DL; Alavi A; Koprowski H; Herlyn D
J Nucl Med; 1986 Nov; 27(11):1739-45. PubMed ID: 3772507
[TBL] [Abstract][Full Text] [Related]
28. Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.
Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
Int J Cancer; 1997 Apr; 71(2):237-45. PubMed ID: 9139849
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.
Zalutsky MR; Bast RC; Knapp RC
Int J Rad Appl Instrum B; 1989; 16(4):405-11. PubMed ID: 2777582
[TBL] [Abstract][Full Text] [Related]
30. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
[TBL] [Abstract][Full Text] [Related]
31. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
32. Human ovarian cancer xenografts in nude mice: characterization and analysis of antigen expression.
Molthoff CF; Calame JJ; Pinedo HM; Boven E
Int J Cancer; 1991 Jan; 47(1):72-9. PubMed ID: 1985883
[TBL] [Abstract][Full Text] [Related]
33. Localization of monoclonal antibody AUA1 and its F(ab')2 fragments in human tumour xenografts: an autoradiographic and immunohistochemical study.
Pervez S; Epenetos AA; Mooi WJ; Evans DJ; Rowlinson G; Dhokia B; Krausz T
Int J Cancer Suppl; 1988; 3():23-9. PubMed ID: 3209296
[TBL] [Abstract][Full Text] [Related]
34. Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics.
Buist MR; Kenemans P; Molthoff CF; Roos JC; Den Hollander W; Brinkhuis M; Baak JP
Int J Cancer; 1995 Apr; 64(2):92-8. PubMed ID: 7615359
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
36. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen.
Molthoff CF; Buist MR; Kenemans P; Pinedo HM; Boven E
J Nucl Med; 1992 Nov; 33(11):2000-5. PubMed ID: 1432162
[TBL] [Abstract][Full Text] [Related]
37. [Preparation of F(ab')2 fragment of monoclonal antibody COC166-9 and its experimental study of radioimmunoimaging for ovarian carcinoma].
Li X; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):152-5. PubMed ID: 9596889
[TBL] [Abstract][Full Text] [Related]
38. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]